Bristol-Myers Squibb Co (NYSE:BMY)’s ipilimumab, or Yervoy as it’s commercially known, was dubbed the skin cancer ‘wonder’ drug by the media when it was licensed for use in the UK in 2011. Bristol-Myers Squibb Co (NYSE:BMY) dropped -0.33 percent to $54.00 Friday on volume of 8.05million shares. The intra-day range of the stock was $53.88…
Shares of Peregrine Pharmaceuticals (NASDAQ: PPHM ) , a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer, dipped as much as 11% after reporting its third-quarter earnings results. Peregrine Pharmaceuticals (NASDAQ:PPHM) stock performance was -8.05% in last session and finished the day at $2.40. Traded volume was 14.14million shares in the last session…
Kuwait’s sovereign investment fund and a pair of investment management firms sued Merck & Co. Inc. (NYSE:MRK) in New Jersey federal court Friday, accusing the company of misleading investors over now-withdrawn arthritis treatment Vioxx, after the plaintiffs previously dropped out of a related multidistrict litigation. Merck & Co. Inc. (NYSE:MRK) belongs to Healthcare sector. Its…
FBR Capital Markets reiterated their hold rating on shares of Marvell Technology Group (NASDAQ:MRVL) in a research report sent to investors on Monday morning. The firm currently has a $19.00 price target on the stock. Marvell Technology Group Ltd. (NASDAQ:MRVL) belongs to Technology sector. Its net profit margin is 11.90% and weekly performance is -4.18%….
On Dec 09, Zymeworks Inc. announced the extension of a research collaboration with Merck & Co. Inc. (NYSE:MRK), known as MSD outside the United States and Canada, that was originally announced in August 2011. In addition, Merck gains expanded access to Zymeworks’ proprietary Azymetric™ platform for the development of novel bi-specific antibody therapeutic candidates. Merck…
On Dec. 5, Huntsman Corporation (NYSE:HUN) announced that the company’s board of directors has declared a $0.125 per share cash dividend on its common stock. The dividend is payable on December 31, 2014, to stockholders of record as of December 15, 2014. Huntsman Corporation (NYSE:HUN) belongs to Basic Materials sector. Its net profit margin is…
